可药性
苄基异喹啉
纳米技术
罂粟
纳米医学
计算机科学
纳米载体
计算生物学
生化工程
青蒿素
化学
化学信息学
药品
药理学
药物发现
药物开发
医学
纳米技术的应用
作者
Zahra Aghaali,Mohammad Reza Naghavi
标识
DOI:10.1016/j.biopha.2025.118557
摘要
The boom in using phytoconstituents for diseases treatment has been fueled by growth in the realm of nanotechnology. This is because nanomedicines not only expand the therapeutic applications of phytochemicals but also refine their physicochemical properties. Among multitude natural compounds prescribed for the treatment of health-related conditions are benzylisoquinoline alkaloids (BIAs). The BIAs predominantly found in opium poppy constitute morphine, noscapine, sanguinarine, papaverine, thebaine, and codeine, with a long history of applications in healing numerous diseases. However, they have problems regarding bioavailability, release, and targeting, which limit their druggability. Integration into nanoparticles has been found to hold great promise for improving the pharmaceutical properties of BIAs, while simultaneously mitigating their potential toxicity. Therefore, this review devotes special focus to recent studies demonstrating a considerable refinement in BIA therapeutic efficacy via the implementation of nanoencapsulation technology. However, the nanoformulations may pose the challenges of cost-efficiency, standard compliance, stability, and safety issue, necessitating further investigations to clear these drawbacks. We also discuss the capability of artificial intelligence (AI), organs-on-a-chip, and carrier-free nanoparticles for toxicity and efficacy assessment and druggability improvement, respectively. Taken together, information present here provides valuable insight into the power of nanoparticles for enriching BIAs and ultimately facilitating their clinical translation.
科研通智能强力驱动
Strongly Powered by AbleSci AI